221
Participants
Start Date
October 26, 2023
Primary Completion Date
November 13, 2024
Study Completion Date
December 11, 2024
SAR441566
Tablet
Placebo
Tablet
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 3480003, Budapest
Investigational Site Number : 3480002, Debrecen
Investigational Site Number : 2680002, Batumi
Investigational Site Number : 2760003, Berlin
Investigational Site Number : 2760004, Blankenfelde-Mahlow
Investigational Site Number : 7240005, Madrid
Investigational Site Number : 7240004, Madrid
Direct Helpers Medical Center Inc- Site Number : 8400023, Hialeah
Driven Research, LLC- Site Number : 8400012, Coral Gables
FXM Clinical Research Miami, LLC- Site Number : 8400016, Miami
FXM Clinical Research Ft. Lauderdale, LLC Site Number : 8400015, Fort Lauderdale
Daxia Trials Site Number : 8400022, Boca Raton
Renaissance Research and Medical Group, Inc- Site Number : 8400018, Cape Coral
Investigational Site Number : 7920001, Kayseri
Investigational Site Number : 1000001, Düsseldorf
Investigational Site Number : 7240003, Manises
Investigational Site Number : 7240002, Zaragoza
Investigational Site Number : 2760002, Witten
Investigational Site Number : 2760001, Frankfurt am Main
Investigational Site Number : 4800001, Quatre Bornes
Center for Clinical Studies, LTD. LLP- Site Number : 8400007, Houston
Center for Clinical Studies, LTD, LLP- Site Number : 8400013, Webster
Jordan Valley Dermatology Center- Site Number : 8400027, South Jordan
Scottsdale Clinical Trials Site Number : 8400025, Scottsdale
Dermatology Research Associates- Site Number : 8400019, Los Angeles
Investigational Site Number : 1560001, Hangzhou
Investigational Site Number : 1560002, Wuxi
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520004, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 0320003, CABA
Investigational Site Number : 0320002, CABA
Investigational Site Number : 1240006, London
Investigational Site Number : 1240002, Waterloo
Investigational Site Number : 2030003, Brno
Investigational Site Number : 2680001, Tbilisi
Investigational Site Number : 3920004, Kamimashiki Gun
Investigational Site Number : 3920003, Sakai-shi
Investigational Site Number : 3920006, Itabashi-ku
Investigational Site Number : 3920002, Tachikawa-shi
Investigational Site Number : 3920005, Ichikawa-shi
Investigational Site Number : 3920001, Yokohama
Investigational Site Number : 6160001, Bydgoszcz
Investigational Site Number : 6160002, Katowice
Investigational Site Number : 6200003, Guimarães
Investigational Site Number : 6200002, Lisbon
Investigational Site Number : 6200001, Lisbon
Investigational Site Number : 7240001, Barcelona
Investigational Site Number : 7240007, Alicante
Investigational Site Number : 7920002, Antalya
Investigational Site Number : 8260001, Manchester
Lead Sponsor
Sanofi
INDUSTRY